愛施德(002416.SZ):2022年擬向相關銀行機構申請綜合授信額度摺合人民幣共234億元
格隆匯12月23日丨愛施德(002416.SZ)公佈,公司於2021年12月23日召開第五屆董事會第二十一次(臨時)會議、第五屆監事會第二十二次(臨時)會議,審議通過了《關於2022年向銀行申請綜合授信額度的議案》,同意公司2022年向相關銀行機構申請綜合授信額度摺合人民幣共計234億元。
公司提議授權董事長黃文輝全權代表公司簽署上述授信額度內的一切授信(包括但不限於授信、借款、擔保、抵押、融資等)有關的合同、協議、憑證等各項法律文件,由此產生的法律、經濟責任全部由公司承擔。
該議案尚須提交股東大會審議,並自股東大會審議通過之日起有效期為一年。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.